Emblem Cannabis (EMC)

[Diogenes of Sinope]

Aleafia Health and Emblem Announce Closing of Arrangement

The Arrangement creates:

The leading Canadian medical cannabis clinic and education centre network with 60,000 patients seen to date

A high-value, highly differentiated product portfolio of oils, capsules and sprays

Scaled production capacity and leading supply with three dedicated cultivation and product innovation facilities and the industry’s largest LP to LP cannabis supply agreement

A national and global distribution platform with provincial supply agreements, retail partnerships and a global expansion

Improved capital markets profile and liquidity, including up-listing to the TSX

A combined entity with a robust cash position

“The acquisition of Emblem rapidly accelerates the execution of Aleafia Health’s strategy and positioning as a vertically integrated, diversified cannabis company with an integrated, highly differentiated consumer ecosystem,” said CEO Geoffrey Benic. “Emblem’s product leadership in the medical and adult-use sectors and highly coveted supply agreements will perfectly complement our cannabis production and clinic operations. This is a transformative transaction that positions Aleafia Health as a global cannabis leader.”

Under the terms of the Arrangement, each former Emblem shareholder is now entitled to receive 0.8377 of a common share in the capital of Aleafia Health, for each Emblem Share held prior to the Arrangement (the “Consideration”). It is anticipated that the Emblem Shares will be delisted from the TSX Venture Exchange (“TSXV”) as of the close of trading on or about March 18, 2019.

https://mailchi.mp/aleafiainc.com/aleafia-health-and-emblem-announce-closing-of-arrangement?e=9bbb842c5f